| Date | Form | Description | Docs | XBRL | Pages |
| 08/27/13 | DEF 14A | Definitive proxy statements |
|
36 | |
| 08/12/13 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
37 | |
| 07/16/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/16/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/19/13 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
56 | |
| 06/19/13 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
124 | |
| 06/19/13 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
Latest News & Events
Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
Read More...